Press release
Neurological Disorders Drugs Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027
The global neurological disorders drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Neurological disorders are characterized by dysfunction in any part of the brain or nervous system, which causes damage or injury. For the treatment of neurological illnesses, a variety of neurological medications such as antipsychotics, antiepileptics, anticholinergics, and analgesics are available on the market.The growth of neurological disorders drug market is expected to witness due to significant investment in R&D. In September 2020, A team led by Rutgers has developed a smart medicine delivery device that supports cure spinal cord injuries and other neurological illnesses by reducing inflammation in injured neural regions. According to a study published in the journal Advanced Materials, the technology, which uses incredibly thin biomaterials implanted in the body, also protects nerve fibres (axons) that connect nerve cells in wounded brain tissues. Ultrathin nanomaterials, sugar polymers, and neuronal proteins make up the team's unique medication delivery method. The mechanism, which releases an anti-inflammatory chemical (methylprednisolone), can support promote tissue repair and recovery after a brain injury by creating a favourable microenvironment. As inflammation is linked to a range of disorders such as CVD, osteoarthritis, diabetes, and cancer, the researchers believes the new approach could pave the way for treating not only central nervous system injuries, however, also other ailments.
To Request a Sample of our Report on Neurological Disorders Drugs Market: https://www.omrglobal.com/request-sample/neurological-disorders-drugs-market
The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, FDA Approval and product innovation to remain competitive in the marketplace. For instance, Aduhelm (aducanumab) was approved by the US Food and Drug Administration in June 2021 for the treatment of Alzheimer's disease, a severe condition that affects 6.2 million Americans. Aduhelm was approved through the accelerated approval pathway, which is reserved for drugs that give a significant therapeutic advantage over existing treatments for serious or life-threatening illnesses. With a mandatory post-approval trial to verify that the medicine achieves the projected clinical benefit, accelerated approval can be based on the drug's effect on a surrogate endpoint that is fairly likely to predict a therapeutic benefit to patients.
Market Coverage
• The market number available for - 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
• By Disease
• By Distribution Channel
Regions covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
Competitive Landscape: Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Sanofi S.A., among others.
(Get 15% Discount on Buying this Report)
A full Report of Neurological Disorders Drugs Market is Available @ https://www.omrglobal.com/industry-reports/neurological-disorders-drugs-market
Global Neurological Disorders Market Report by Segment
By Disease
• Epilepsy
• Parkinson's disease
• Alzheimer's disease
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Neurological Disorders Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Disorders Drugs Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027 here
News-ID: 2582135 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Neurological
Major Growth Driver Identified in 2025 Neurological Biomarkers Market: Rising Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurological Biomarkers Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of neurological biomarkers has seen a swift augmentation in the past few years. Projected to escalate from $10.7 billion in 2024 to $11.96 billion in 2025, it holds a compound annual growth…
Neurological Biomarkers Market : An Overview
Introduction:
Neurological biomarkers are biological markers that provide insight into the physiological, pathological, and pharmacological responses of the nervous system. These biomarkers play a critical role in diagnosing, monitoring, and treating neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. With growing advancements in genomics, proteomics, and molecular biology, neurological biomarkers have emerged as essential tools in precision medicine, allowing for early detection and personalized treatment plans for…
Neurological Biomarkers Market: An Overview
Introduction:
Neurological biomarkers refer to measurable indicators that can be used to detect or monitor neurological diseases or disorders. These biomarkers provide critical insights into the diagnosis, progression, and treatment of neurological conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. Neurological biomarkers are typically measured in bodily fluids like cerebrospinal fluid (CSF), blood, or even imaging techniques like MRI. With advancements in molecular biology, genomics, and…
Nurturing Neurological Wellness: Insights into the Global Neurological Disorder …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Neurological disorders represent a significant healthcare challenge, affecting millions worldwide and encompassing a diverse spectrum of conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, among others. In the quest for effective management and treatment, pharmaceutical interventions play a pivotal role. As we embark on a journey to explore the global neurological disorder drugs market, we unravel the complex interplay of resin types, applications, technologies, end-use industries, and…
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040
This latest report researches the industry structure, sales, revenue,…
Neurological Disorder Drugs Market - Advancing Neurological Health through Innov …
Newark, New Castle, USA - new report, titled Neurological Disorder Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurological Disorder Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurological Disorder Drugs market. The report offers an overview of…